Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, Punzi V, Luotti S, Bottino N, Biagianti B, Moglia C, Fuda G, Gualtierotti R, Blasi F, Canetta C, Montano N, Tettamanti M, Camera G, Grimoldi M, Negro G, Rifino N, Calvo A, Brambilla P, Biroli F, Bandera A, Nobili A, Stocchetti N, Sessa M, Zanier ER. Bonetto V, et al. Among authors: gualtierotti r. Front Immunol. 2022 Dec 15;13:1070379. doi: 10.3389/fimmu.2022.1070379. eCollection 2022. Front Immunol. 2022. PMID: 36591311 Free PMC article.
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia.
Bandera A, Aliberti S, Gualtierotti R, Baldini M, Blasi F, Cesari M, Costantino G, Fracanzani AL, Gori A, Montano N, Monzani V, Nobili A, Peyvandi F, Pesenti A, Prati D, Valenti L, Fusetti G, Scudeller L, Bosari S; COVID-19 Network; Scientific Direction; Department of Transfusion Medicine and Biobank; Infectious Diseases Unit; Internal Medicine, Hemophilia and Thrombosis Center and Fondazione Luigi Villa; Internal Medicine, Immunology and Allergies; Respiratory Unit and Cystic Fibrosis Adult Center; Cardiology Unit; Emergency Medicine; Acute Internal Medicine; Internal Medicine; Internal Medicine and Metabolic Diseases; Geriatric Unit; Istituto di Ricerche Farmacologiche Mario Negri IRCCS. Bandera A, et al. Among authors: gualtierotti r. Clin Microbiol Infect. 2020 Nov;26(11):1576-1578. doi: 10.1016/j.cmi.2020.06.028. Epub 2020 Jun 30. Clin Microbiol Infect. 2020. PMID: 32619733 Free PMC article. No abstract available.
Anti-emicizumab antibodies do not cross-react with mim8 in vitro.
Valsecchi C, Gualtierotti R, Arcudi S, Ciavarella A, Siboni SM, Schiavone L, Beeg M, Gobbi M, Peyvandi F. Valsecchi C, et al. Among authors: gualtierotti r. Res Pract Thromb Haemost. 2023 Aug 8;7(6):102161. doi: 10.1016/j.rpth.2023.102161. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37694267 Free PMC article. No abstract available.
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients.
Capecchi M, De Leo P, Abbattista M, Mancini I, Agosti P, Biganzoli M, Suffritti C, Ferrari B, Lecchi A, La Marca S, Padovan L, Scalambrino E, Clerici M, Tripodi A, Artoni A, Gualtierotti R, Peyvandi F. Capecchi M, et al. Among authors: gualtierotti r. Haematologica. 2023 Nov 1;108(11):3152-3155. doi: 10.3324/haematol.2022.282478. Haematologica. 2023. PMID: 36951158 Free PMC article. No abstract available.
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis.
Arcudi S, Gualtierotti R, Scalambrino E, Clerici M, Hassan S, Begnozzi V, Boccalandro EA, Novembrino C, Valsecchi C, Palla R, Peyvandi F. Arcudi S, et al. Among authors: gualtierotti r. Blood Adv. 2024 Mar 26:bloodadvances.2023012285. doi: 10.1182/bloodadvances.2023012285. Online ahead of print. Blood Adv. 2024. PMID: 38531053
125 results